Abstract
Breast cancer stem cells are well known to resist the traditional methods like chemo and radio therapy. Aldehyde dehydrogenase 1 (ALDHIA1) and glycogen synthase kinase-3 β (GSK-3β) are the two selected proteins for study, due to their overexpression and upregulation in breast cancer cells. Curcumin, the yellow pigment of the spice turmeric, is widely reported as an antioxidant and acts as a synergist along with traditional drugs. Under hypoxic conditions, it gets converted to free radical which causes apoptosis. Three naturally occurring curcuminoids, i.e. curcumin, demethoxycurcumin, and bisdemethoxycurcumin along with five derivatives/analogues of curcumin, viz. 4,4′-di-O-(carboxy-methyl)-curcumin, 4-O-(2-hydroxyethyl)curcumin, 4,4′-di-O-allyl-curcumin, 4,4′-di-O-(acetyl)-curcumin, and 3,3′-bisdemethylcurcumin were synthesized and evaluated for their anti-breast cancer potential by docking simulation and assessment of their antioxidant character, studied via 2, 2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS·+) radical cation scavenging assay, 2,2-diphenyl-1-picrylhydrazyl (DPPH·) radical, and ferric reducing ability potential (FRAP) assay. A co-relation between structure and activity of curcuminoids/its analogues and derivatives has been worked out.
Similar content being viewed by others
References
Aggarwal B. B., Sundaram C., Malani N., & Ichikawa H. (2007). Curcumin: the Indian solid gold. Advances in Experimental Medicine and Biology, 595, 1–75.
John D. (1984). One hundred useful raw drugs of the Kani tribes of Trivandrum Forest Division, Kerala, India. Pharmaceutical Biology, 22(1), 17–39.
Mishra S., Karmodiya K., Suroliab N., & Surolia A. (2008). Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorganic & Medicinal Chemistry Letters, 16(6), 2894–2902.
Singh D. B., Gupta M. K., Kesharwani R. K., & Misra K. (2013). Comparative docking and ADMET study of some curcumin derivatives and herbal congeners targeting β-amyloid. Network Modeling Analysis in Health Informatics and Bioinformatics, 2(1), 13–27.
Kesharwani R. K., & Misra K. (2011). Prediction of binding site for curcuminoids at human topoisomerase II a protein; an in silico approach. Current Science, 101(8), 1060–1065.
Singh D. V., Agarwal S., Kesharwani R. K., & Misra K. (2013). 3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: interaction with thioredoxin reductase. Interdisciplinary Sciences: Computational Life Sciences, 5(4), 286–295.
Anand P., Thomas S. G., Kunnumakkara A. B., Sundaram C., Harikumar K. B., Sung B., Tharakan S. T., Misra K., Priyadarsini I. K., Rajasekharan K. N., & Aggarwal B. B. (2008). Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochemical Pharmacology, 76(11), 1590–1611.
Singh P., & Rizvi S. I. (2013). Curcumin activates erythrocyte membrane acetylcholinesterase. Letters in Drug Design & Discovery, 10(6), 550–556.
Ma I., & Allan A. L. (2011). The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Reviews and Reports, 7(2), 292–306.
Lohberger, B., Rinner, B., Stuendl, N., Absenger, M., Liegl-Atzwanger, B. Walzer S. M., Windhager, R., & Leithner A. (2012). Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma. PloS One, 7(8), e43664.
Abdullah, L. N., & Chow, E. K. (2013). Mechanisms of chemoresistance in cancer stem cells. Clinical and Translational Medicine, 2(3).
Keysar, S. B., & Jimeno, A. (2010). More than markers: biological significance of cancer stem cell-defining molecules. Molecular Cancer Therapeutics, 9(9), 2450–2457.
Kakarala M., Brenner D. E., Khorkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., & Wicha M. S. (2010). Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Research and Treatment, 122(3), 777–785.
Bustanji Y., Taha M. O., Almasri I. M., Al-Ghussein M. A., Mohammad M. K., & Alkhatib H. S. (2009). Inhibition of glycogen synthase kinase by curcumin: investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry, 24(3), 771–778.
Cheng A. L., Hsu C. H., Lin J. K., Hsu M. M., Ho Y. F., Shen T. S., Ko J. Y., Lin J. T., Lin B. R., Ming-Shiang W., Yu H. S., Jee S. H., Chen G. S., Chen T. M., Chen C. A., Lai M. K., Pu Y. S., Pan M. H., Wang Y. J., Tsai C. C., & Hsieh C. Y. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research, 21(4B), 2895–2900.
Aggarwal B. B., & Shishodia S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical Pharmacology, 71(10), 1397–1421.
Dubey S. K., Sharma A. K., Narain U., Misra K., & Pati U. (2008). Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. European Journal of Medicinal Chemistry, 43(9), 1837–1846.
Anand P., Nair H. B., Sung B., Kunnumakkara A. B., Yadav V. R., Tekmal R. R., & Aggarwal B. B. (2010). Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochemical Pharmacology, 79(3), 330–338.
Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., & Maitra A. (2007). Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. Journal of Nanobiotechnology, 5, 3.
Tiyaboonchai W., Tungpradit W., & Plianbangchang P. (2007). Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics, 337(1–2), 299–306.
Li, L., Braiteh, F. S., & Kurzrock, R. (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer, 104(6), 1322-1331.
Mishra S., Narain U., Mishra R., & Misra K. (2005). Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorganic & Medicinal Chemistry, 13(5), 1477–1486.
Mishra S., Kapoor N., Ali A. M., Pardhasaradhi B. V., Kumari A. L., Khar A., & Misra K. (2005). Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Radical Biology and Medicine, 38(10), 1353–1360.
Kumar S., Narain U., Tripathi S., & Misra K. (2001). Syntheses of curcumin bioconjugates and study of their antibacterial activities against beta-lactamase-producing microorganisms. Bioconjugate Chemistry, 12(4), 464–469.
Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., & Srinivas P. S. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64(4), 353–356.
Mosley C. A., Liotta D. C., & Snyder J. P. (2007). Highly active anticancer curcumin analogues. Advances in Experimental Medicine and Biology, 595, 77–103.
Wehrli, C. (2007). Curcumin synthesis, WO 2007/110168A1, World Intellectual Property Organization.
Changtam C., Hongmanee P., & Suksamrarn A. (2010). Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. European Journal of Medicinal Chemistry, 45(10), 4446–4457.
Venkateswarlu S., Ramachandra M. S., & Subbaraju G. V. (2005). Synthesis and biological evaluation of polyhydroxycurcuminoids. Bioorganic & Medicinal Chemistry, 13, 6374–6380.
Moore S. A., Baker H. M., Blythe T. J., Kitson K. E., Kitson T. M., & Baker E. N. (1998). Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. Structure, 6(12), 1541–1551.
Gentile G., Merlo G., Pozzan A., Bernasconi G., Bax B., Bamborough P., Bridges A., Carter P., Neu M., Yao G., Brough C., Cutler G., Coffin A., & Belyanskaya S. (2012). 5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK−3 inhibitors. Bioorganic & Medicinal Chemistry Letters, 22(5), 1989–1994.
Berman H. M., Westbrook J., Feng Z., Gilliland G., Bhat T. N., Weissig H., Shindyalov I. N., & Bourne P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242.
Durdagi S., Duff H. J., & Noskov S. Y. (2011). Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain. Journal of Chemical Information and Modeling, 51(2), 463–474.
ACD/ChemSketch, version 8.0, 2006. Advanced Chemistry Development, Inc., Toronto ON, Canada, www.acdlabs.com.
Albers, H. M. H. G., Hendrickx, L. J. D., van Tol, R. J. P., Hausmann, J., Perrakis, A., & Ovaa, H. (2011). Structure-based design of novel boronic acid-based inhibitors of autotaxin. Journal of Chemical Information and Modeling, 54(13), 4619-4626.
Maestro (v7.0.113)—a unified interface for all Schrodinger products, developed and marketed by Schrodinger, LLC. NY, Copyright 2005; http://www.schrodinger.com.
Friesner R. A., Murphy R. B., Repasky M. P., Frye L. L., Greenwood J. R., Halgren T. A., Sanschagrin P. C., & Mainz D. T. (2006). Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196.
Gadakar P. K., Phukan S., Dattatreya P., & Balaji V. N. (2007). Pose prediction accuracy in docking studies and enrichment of actives in the active site of GSK-3beta. Journal of Chemical Information and Modeling, 47(4), 1446–1459.
Miller J. N., & Rice-Evans C. A. (1997). Factors influencing the antioxidant activity determined by the ABTS+ radical cation assay. Free Radical Research, 26(3), 195–199.
Szabo M. R., Iditoiu C., Chambre D., & Lupea A. X. (2007). Improved DPPH determination for antioxidant activity spectrophotometric assay. Chemical Papers- Slovak Academy of Sciences, 61(3), 214–216.
Benzie I. F., & Strain J. J. (1996). The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Analytical Biochemistry, 239(1), 70–76.
Rice-Evans C. A., Miller N. J., & Paganga G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine, 20(7), 933–956.
Lissi E. A., Modak B., Torres R., Escobar G., & Urzua A. (1999). Total antioxidant potential of resinous exudates from Heliotropium species, and a comparison of the ABTS and DPPH methods. Free Radical Research, 30(6), 471–477.
Duda-Chodak A., Tarko T., Sroka P., & Satora P. (2008). Antioxidant activity of different kinds of commercially available teas—diversity and changes during storage. Electronic Journal of Polish Agricultural Universities, 11(4), 1–7.
Furiga A., Lonvaud-Funel A., & Badet C. (2009). In vitro study of antioxidant capacity and antibacterial activity on oral anaerobes of a grape seed extract. Food Chemistry, 113(4), 1037–1040.
Singh P., & Rizvi S. I. (2012). Anti-oxidative effect of curcumin against tert-butylhydroperoxide induced oxidative stress in human erythrocytes. The Natural Products Journal, 2(1), 69–73.
Singh, P., Kesharwani, R. K., Misra, K., & Rizvi, S. I. (2015). The modulation of erythrocyte Na+/K+- ATPase activity by curcumin. Journal of Advanced Research, doi:10.1016/j.jare.2014.12.007.
Acknowledgments
Rajesh Kr. Kesharwani acknowledges the Indian Council of Medical Research (ICMR), New Delhi, India, for providing senior research fellowship and wishes to thank the Director, IIIT-A, for providing computational facilities to carry out research work smoothly. Prabhakar Singh acknowledges the Council of Scientific and Industrial Research (CSIR), New Delhi, India, for providing senior research fellowship.
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kesharwani, R.K., Srivastava, V., Singh, P. et al. A Novel Approach for Overcoming Drug Resistance in Breast Cancer Chemotherapy by Targeting new Synthetic Curcumin Analogues Against Aldehyde Dehydrogenase 1 (ALDH1A1) and Glycogen Synthase Kinase-3 β (GSK-3β). Appl Biochem Biotechnol 176, 1996–2017 (2015). https://doi.org/10.1007/s12010-015-1696-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-015-1696-x